Rutgers University Study of the Genetics of Pulmonary Hypertension
NCT07217522
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this observational study is to learn more about how genes impact the risk of pulmonary hypertension. Anyone 18 or older living in the US is eligible, and a diagnosis of PH is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Pulmonary Hypertension
- Pulmonary Arterial Hypertension
- Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
- Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
- Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)
- Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)
- Pulmonary Arterial Hypertension of Congenital Heart Disease
- Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Rutgers, The State University of New Jersey
- Last updated on ClinicalTrials.gov
- November 3, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New Jersey · 1
- Rutgers University, Piscataway, New Jersey 08854 · Piscataway, NJ
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.